Publications
52 publications
Funding
9 grantsView NIH portfolio on RePORTER ↗
Active
6 grants- MPIUM1AI191237-02INSPIRE: Innovative Strategies for Personalized Immunotherapies and Reservoir EradicationNIAID · 2025–2030 · via NIH RePORTER
- MPIUM1AI164565-06REACH: Research Enterprise to Advance a Cure for HIVNIAID · 2021–2028 · via NIH RePORTER
- PIU01AI169385-05Defining the mechanisms of HIV resistance to bNAbs in humansNIAID · 2022–2027 · via NIH RePORTER
- PIU01AI167786-04First-in-human study of a potent anti-HBsAg neutralizing antibodyNIAID · 2023–2027 · via NIH RePORTER
- MPIP01AI165075-01S1Broad neutralization of pandemic threat coronavirusesNIAID · 2022–2025 · via NIH RePORTER
- MPIU01AI145921-05Immunologic control of HIV-1 through combination bNAbs and biologics.NIAID · 2019–2025 · via NIH RePORTER
Completed grants (3)
- PIU01AI129825-053BNC117 and 10-1074 to suppress HIV-1 replication and reduce the reservoirNIAID · 2017–2022 · via NIH RePORTER
- MPIU01AI118536-033BNC117 mAb in HIV-infected subjects on combination ARTNIAID · 2015–2018 · via NIH RePORTER
- PIK23AI084855-05Characterization of the immunity induced by a DEC205-targeted HIV vaccineNIAID · 2009–2014 · via NIH RePORTER
News mentions
2 mentionsView all WCM news ↗
- NIH Grant Funds Effort to Target the Root of HIV PersistenceAugust 15, 2025
A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to find ways to remove latent HIV from the cells of individuals with HIV.
- New Lab Test to Detect Persistent HIV Strains in Africa May Aid Search for CureJuly 2, 2024
A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a vital tool in the search for an HIV cure that will benefit patients around the world.